DaVita Venture Group

DaVita Venture Group is the corporate venture capital arm of DaVita Inc., dedicated to investing in, acquiring, and co-developing products, solutions, and businesses that enhance care for patients with kidney disease and related conditions. Their strategic focus includes care delivery models, life sciences, and digital health, aiming to transform patient care through technological advancements and innovative approaches.

The group typically invests in early-to-mid stage, growth-oriented businesses, often participating in Series A and beyond funding rounds with investments ranging from $1 million to $10 million. They take an active role in their portfolio companies, often through board observerships or director roles, and provide support beyond capital, including clinical and value-based care delivery expertise, business development, hiring, and technical support.

By fostering partnerships with healthcare innovators, DaVita Venture Group seeks to accelerate advancements in kidney care, striving to improve patient outcomes and quality of life through strategic investments and collaborations.